A platform to eliminate all viruses

Hebrew University startup ViroBlock has reported preliminary success of its platform for rapidly generating anti-viral therapies. Its channel blockers inhibit proteins expressed by current and emerging viruses, including COVID-19 and variants, influenza, Zika, West Nile, Hepatitis B and more.

https://www.pharmiweb.com/press-release/2022-06-27/viroblock-a-hebrew-university-startup-announces-preliminary-success-of-its-anti-viral-drug-platform-in-new-study

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.